Source:http://linkedlifedata.com/resource/pubmed/id/12430666
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-14
|
| pubmed:abstractText |
Recipient exposure to allogeneic donor WBCs results in transfusion complications for selected populations of recipients. Whether or not WBC reduction should be universally applied is highly controversial.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1114-22
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:articleTitle |
A prospective, randomized clinical trial of universal WBC reduction.
|
| pubmed:affiliation |
Blood Transfusion Service, Massachusetts General Hospital, Boston 02114, USA. sdzik@partners.org
|